Search
User Profile
Change
Select your user profile
Product portfolio

Donor Screening – Serology Solutions

Bringing safety, reliability and efficiency to donor screening

Roche Diagnostics serology assays and instruments can be used to perform a broad range of immunoassays and offer various options to suit your throughput needs.

Roche Elecsys® assays include highly specific and sensitive serology tests to detect infectious diseases. The test is based on ECL (ElectroChemiLuminescence) technology and delivers reliable results.1-10 All serology screening assays detect the major viral genotypes and variants found worldwide. They show very high seroconversion sensitivity, and their very high specificity and clear cut-off separation of positive and negative results reduces the need for retesting.1-10

 

View all products

Ensuring patient safety during blood transfusions

Ensuring patient safety during blood transfusions

Comprehensive variant coverage to ensure reliable detection of infectious samples1-10

Excellent sensitivity to allow for detection of early infections1-10

Automated sample handling reduces risk of manual handling errors

Improving efficiency by automating screening tests

Improving efficiency by automating screening tests

Decrease the need for retesting and minimize loss of donations due to high specificity of Elecsys® assays1-10

Allow your staff to focus on important tasks by achieving up to 5 hours of walkaway time12

Supporting a consistent and reliable blood supply

Supporting a consistent and reliable blood supply

Optimized uptime (>99,2%)11 of cobas® instruments that ensure the timely release of blood products

Validated workflows for cross-contamination compliance13

Assurance in service with skilled local Roche support teams available when you need them



Explore Roche serology assays and analyzers for donor screening

 

A comprehensive state-of-the-art portfolio to deliver an integrated solution on the same serology instrument. 

 

Donor screening assay

 

  • Elecsys® HIV Duo*
  • Elecsys® HIV combi PT
  • Elecsys® Anti-HCV II
  • Elecsys® HBsAg II
  • Elecsys® Anti-HBc II
  • Elecsys® Anti-HBs II
  • Elecsys® HTLV-I/II
  • Elecsys® Syphilis
  • Elecsys® CMV IgG
  • Elecsys® Chagas

Additional serology assays

 

  • Elecsys® Anti-HAV
  • Elecsys® Anti-HAV-IgM
  • Elecsys® Anti-HBc IgM
  • Elecsys® Anti-HBe
  • Elecsys® CMV IgG avidity
  • Elecsys® CMV IgM
  • Elecsys® EBV**
  • Elecsys® HBeAg
  • Elecsys® HBsAg II quant II
  • Elecsys® HCV Duo*/**

 

 

  • Elecsys® HIV-Ag
  • Elecsys® HSV-1 IgG
  • Elecsys® HSV-2 IgG
  • Elecsys® Rubella
  • Elecsys® Rubella IgM
  • Elecsys® Toxo IgG
  • Elecsys® Toxo IgG avidity
  • Elecsys® Toxo IgM
  • Elecsys® Zika IgG

*For cobas e801; **In development

Note: Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability. Serology portfolio in addition is not available in USA, Canada and Philippines. 

Which serology solution best fits your needs?

cobas e 801 module

cobas e 801 module

  • Available for the cobas® 8000 modular analyzer series
  • High to extra high volume workload
  • Throughput of up to 300 tests per hour per module
  • Modular and scalable to four analytical modules
  • Continuous reagent cassette loading/unloading during operation
See more
cobas e 411

cobas e 411 analyzer

  • Available for the cobas® 4000 analyzer series
  • Low volume workload
  • Throughput of up to 75 tests per hour
See more

Note: Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability. Serology portfolio in addition is not available in USA, Canada and Philippines.

 

Designed to work together

Explore Roche's donor screening solutions

...
    ...

    Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability. Serology portfolio in addition is not available in USA, Canada and Philippines.

     

    References

    1. Mühlbacher, A., et al. (2013). Med Microbiol Immunol 202, 77–86.
    2. Mühlbacher, A., et al. (2008). Med Microbiol Immunol 197, 55–64.
    3. Esteban, J., et al. (2013). J Med Virol 85, 1362–1368.
    4. Ly, T.D., et al. (2012). J Clin Virol 55, 121–127.
    5. Louisirirotchanakul, S., et al. (2010). J Med Virol 82, 755–762.
    6. Jia, J.D., et al. (2009). Med Microbiol Immunol 198, 263–269.
    7. Laperche, S., et al. (2017). J. Clin. Microbiol 55, 2180-2187.
    8. Kremastinou, J., et al. (2016). J. Clin. Microbiol 54, 2330-2336.
    9. Sommese, L., et al. (2014). Scandinavian Journal of Infectious Diseases 46, 660–664.
    10. Schmidt, M., et al. (2015). Vox Sanguinis 109, 114-21.
    11. Data on file. Roche Diagnostics International Ltd.
    12. Data on file. Roche Diagnostics International Ltd.
    13. Roche. (2016). Declaration of Serology and NAT testing compliance.  |  Iordanoaia, N., et al. (2016 September). Cross-contamination​ ​Compliance of cobas p 612 pre-analytical system in use with cobas® 6800/8800 Systems. Poster presented at ISBT, Dubai, UAE.
    Serology products
    Found 0 results in
    Search
    Filters
    ...
      ...